Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials

Objectives: This study systematically reviewed the published literature from clinical trials on the efficacy and immunogenicity of single-dose HPV vaccination compared to multidose schedules or no HPV vaccination. Methods: Four databases were searched for relevant articles published from Jan-1999 to...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Hilary S. Whitworth, Sandra Mounier-Jack, Edward M. Choi, Katherine E. Gallagher, Natasha Howard, Helen Kelly, Gladys Mbwanji, Aimée R Kreimer, Partha Basu, Ruanne Barnabas, Mélanie Drolet, Marc Brisson, Deborah Watson-Jones
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	Elsevier 2024-08-01
Цуврал:	Vaccine: X
Нөхцлүүд:	Human papillomavirus Vaccine Dosage Efficacy Immunogenicity
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2590136224000597

Ижил төстэй зүйлс

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
-н: Mingzhu Li, зэрэг
Хэвлэсэн: (2023-03-01)

The effect of perceived psychological stress on the immunogenicity of the quadrivalent human papillomavirus vaccine in males
-н: Rebecca F. Wu, зэрэг
Хэвлэсэн: (2017-03-01)

Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals
-н: Xiao-Juan Yu, зэрэг
Хэвлэсэн: (2020-07-01)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
-н: Suzanne M. Garland, зэрэг
Хэвлэсэн: (2022-11-01)

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial
-н: Vu Dinh Thiem, зэрэг
Хэвлэсэн: (2021-07-01)

Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies
-н: Anna R. Giuliano, зэрэг
Хэвлэсэн: (2025-12-01)

Human papillomavirus vaccine: An update on recent developments and review of real world data on efficacy
-н: Shalini Rajaram, зэрэг
Хэвлэсэн: (2023-01-01)

A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine
-н: Dan Xu, зэрэг
Хэвлэсэн: (2024-11-01)

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age
-н: Tianmeng Wen, зэрэг
Хэвлэсэн: (2024-12-01)

Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness
-н: P. Lemieux-Mellouki, зэрэг
Хэвлэсэн: (2017-12-01)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
-н: Paulina N. Naupu, зэрэг
Хэвлэсэн: (2020-12-01)

Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses
-н: Lívia Zignago Moreira dos Santos, зэрэг
Хэвлэсэн: (2024-12-01)

Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up
-н: Sven-Eric Olsson, зэрэг
Хэвлэсэн: (2020-12-01)

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior
-н: Iacopo Baussano, зэрэг
Хэвлэсэн: (2016-01-01)

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types
-н: Katrina M. Nolan, зэрэг
Хэвлэсэн: (2023-04-01)

Application of reverse cumulative distribution curve and scaled logit model in determining optimal immunogenic dose and prediction of protection of EV71 vaccines
-н: Lairun Jin, зэрэг
Хэвлэсэн: (2025-12-01)

Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial
-н: Zhao-Jun Mo, зэрэг
Хэвлэсэн: (2022-11-01)

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years
-н: Ivette Maldonado, зэрэг
Хэвлэсэн: (2022-11-01)

Sleep and vaccine administration time as factors influencing vaccine immunogenicity
-н: Eun Seok Kim, зэрэг
Хэвлэсэн: (2022-03-01)

In-silico Analysis of Human Papillomavirus – 45 E6, E7 & L1 Proteins as Potential Immunogens
-н: Shruthi Padavu, зэрэг
Хэвлэсэн: (2023-03-01)

Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant
-н: Karina Takesaki Miyaji, зэрэг
Хэвлэсэн: (2024-11-01)

Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countriesResearch in context
-н: Kiesha Prem, зэрэг
Хэвлэсэн: (2024-08-01)

Discrepancies in the evaluation of the safety of the human papillomavirus vaccine
-н: Jorge L Cervantes, зэрэг
Хэвлэсэн: (2018-05-01)

Comparison of immunogenicity between hepatitis B vaccines with different dosages and schedules among healthy young adults in China: A 2-year follow-up study
-н: Zhen-Zi Wang, зэрэг
Хэвлэсэн: (2018-06-01)

Factors influencing the immunogenicity of influenza vaccines
-н: Simin Wen, зэрэг
Хэвлэсэн: (2021-08-01)

Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial
-н: Ying-Ying Su, зэрэг
Хэвлэсэн: (2020-07-01)

Human Papillomavirus Vaccine: A New Opportunity for The Treatment of Human Papillomavirus Infections
-н: Sneha Ambwani, зэрэг
Хэвлэсэн: (2014-06-01)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
-н: Juan Li, зэрэг
Хэвлэсэн: (2021-10-01)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
-н: Eva Hong, зэрэг
Хэвлэсэн: (2017-03-01)

Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials
-н: Chantal Sauvageau, зэрэг
Хэвлэсэн: (2020-03-01)

Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
-н: Jiawei Xu, зэрэг
Хэвлэсэн: (2024-05-01)

Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
-н: Steffi Silling, зэрэг
Хэвлэсэн: (2014-01-01)

Influences of obesity on the immunogenicity of Hepatitis B vaccine
-н: Fang Liu, зэрэг
Хэвлэсэн: (2017-05-01)

Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis
-н: Sara Carazo, зэрэг
Хэвлэсэн: (2020-03-01)

Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review
-н: Mallory K. Ellingson, зэрэг
Хэвлэсэн: (2023-08-01)

Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection
-н: Maria Zurek Munk-Madsen, зэрэг
Хэвлэсэн: (2018-04-01)

Micronutrients to Support Vaccine Immunogenicity and Efficacy
-н: Philip C. Calder, зэрэг
Хэвлэсэн: (2022-04-01)

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study
-н: Ingrid Herta Rotstein Grein, зэрэг
Хэвлэсэн: (2020-11-01)

Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-Analysis
-н: Andrew M. Secor, зэрэг
Хэвлэсэн: (2020-10-01)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
-н: Rodrigo Luiz Carregaro, зэрэг
Хэвлэсэн: (2023-08-01)